Widely regarded as a founder of cell free DNA (cfDNA) technology, Professor Dennis Lo is now pioneering investigation into the emerging science of fragmentomics. If you were at were at our recent ...
DURHAM, N.C., April 14, 2026 (GLOBE NEWSWIRE)-- GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Dennis Lo (left) is the Associate Dean of Research for the Faculty of Medicine at the Chinese University of Hong Kong (China). For the last 25 years, his lab has studied circulating DNA to develop ...
LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (Nasdaq: RENB), a company at the forefront of AI-driven healthcare innovation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results